GENE ONLINE|News &
Opinion
Blog

2021-06-15| IPOSpecial

Is the Path to Public Market Smooth? A Candid Discussion on SPACs

by Daniel Ojeda
Share To
There are multiple ways for a company to raise money, from venture capital to the public offering of common stocks. One method that has garnered a lot of attention recently is the Special Purpose Acquisition Company (SPAC).
Recognizing the prominent role of SPACs in shaping the growth of biotech companies, an expert panel shared their experiences at the BIO Digital 2021 conference. The panel comprised of:

GO Prime with only $1.49 now

LATEST
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
EVENT
Scroll to Top